Regulatory role of ceRNA network in B lymphocytes of patients with immune thrombocytopenia

References

• Cooper N, Ghanima W. Immune thrombocytopenia. N Engl J Med. 2019;381(10):1–12.
   PubMed Web of Science ®Google Scholar
• Swinkels M, Rijkers M, Voorberg J, et al. Emerging concepts in immune thrombocytopenia. Front Immunol. 2018;9:880.
   PubMed Web of Science ®Google Scholar
• Godeau B. B-cell depletion in immune thrombocytopenia. Semin Hematol. 2013;50 Suppl 1(Suppl 1):S75–S82.
   PubMedGoogle Scholar
• Canales-Herrerias P, Crickx E, Broketa M, et al. High-affinity autoreactive plasma cells disseminate through multiple organs in patients with immune thrombocytopenic purpura. J Clin Invest. 2022;132(12):e153580.
   PubMed Web of Science ®Google Scholar
• Zhao M, He X, Yang J, et al. Aberrant microRNA expression in B lymphocytes from patients with primary warm autoimmune haemolytic anaemia. Autoimmunity. 2021;54(5):264–274.
   PubMed Web of Science ®Google Scholar
• Li JQ, Hu SY, Wang ZY, et al. MicroRNA-125-5p targeted CXCL13: a potential biomarker associated with immune thrombocytopenia. Am J Transl Res. 2015;7(4):772–780.
   PubMed Web of Science ®Google Scholar
• Li H, Zhao H, Xue F, et al. Reduced expression of MIR409-3p in primary immune thrombocytopenia. Br J Haematol. 2013;161(1):128–135.
   PubMed Web of Science ®Google Scholar
• Jathar S, Kumar V, Srivastava J, et al. Technological developments in lncRNA biology. Adv Exp Med Biol. 2017;1008:283–323.
   PubMed Web of Science ®Google Scholar
• Panda AC, Abdelmohsen K, Gorospe M. SASP regulation by noncoding RNA. Mech Ageing Dev. 2017;168:37–43.
   PubMed Web of Science ®Google Scholar
• Tsai CY, Hsieh SC, Lu CS, et al. Cross-talk between mitochondrial dysfunction-provoked oxidative stress and aberrant noncoding RNA expression in the pathogenesis and pathophysiology of SLE. Int J Mol Sci. 2019;20(20):5183.
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344–352.
   PubMed Web of Science ®Google Scholar
• Li LJ, Zhao W, Tao SS, et al. Competitive endogenous RNA network: potential implication for systemic lupus erythematosus. Expert Opin Ther Targets. 2017;21(6):639–648.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Chen X, Wu H, et al. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis. J Transl Med. 2021;19(1):18.
   PubMed Web of Science ®Google Scholar
• Fan Z, Wang X, Li P, et al. Systematic identification of lncRNA-associated ceRNA networks in immune thrombocytopenia. Comput Math Methods Med. 2020;2020:6193593–6193598.
   PubMed Web of Science ®Google Scholar
• Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780–3817.
   PubMed Web of Science ®Google Scholar
• Godeau B, Stasi R. Is B-cell depletion still a good strategy for treating immune thrombocytopenia? Presse Med. 2014;43(4 Pt 2):e79–e85.
   PubMedGoogle Scholar
• Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. 2017;6(2):16.
   PubMed Web of Science ®Google Scholar
• Zhang JM, Zhu XL, Xue J, et al. Integrated mRNA and miRNA profiling revealed deregulation of cellular stress response in bone marrow mesenchymal stem cells derived from patients with immune thrombocytopenia. Funct Integr Genomics. 2018;18(3):287–299.
   PubMed Web of Science ®Google Scholar
• Sun Y, Hou Y, Meng G, et al. Proteomic analysis and microRNA expression profiling of plasma-derived exosomes in primary immune thrombocytopenia. Br J Haematol. 2021;194(6):1045–1052.
   PubMed Web of Science ®Google Scholar
• Mo ML, Jiang JM, Long XP, et al. miR-144-3p aggravated cartilage injury in rheumatoid arthritis by regulating BMP2/PI3K/akt axis. Mod Rheumatol. 2022;32(6):1064–1076.
   PubMed Web of Science ®Google Scholar
• Yao Q, Wang X, He W, et al. Circulating microRNA-144-3p and miR-762 are novel biomarkers of graves’ disease. Endocrine. 2019;65(1):102–109.
   PubMed Web of Science ®Google Scholar
• Li N, Liu L, Liu Y, et al. miR-144-3p suppresses osteogenic differentiation of BMSCs from patients with aplastic anemia through repression of TET2. Mol Ther Nucleic Acids. 2020;19:619–626.
   PubMedGoogle Scholar
• Bian H, Zhou Y, Zhou D, et al. The latest progress on miR-374 and its functional implications in physiological and pathological processes. J Cell Mol Med. 2019;23(5):3063–3076.
   PubMed Web of Science ®Google Scholar
• Guan D, Li Y, Cui Y, et al. Down-regulated miR-374c and Hsp70 promote Th17 cell differentiation by inducing Fas expression in experimental autoimmune encephalomyelitis. Int J Biol Macromol. 2020;154:1158–1165.
   PubMed Web of Science ®Google Scholar
• Cheng J, Wu R, Long L, et al. miRNA-451a targets IFN regulatory factor 8 for the progression of systemic lupus erythematosus. Inflammation. 2017;40(2):676–687.
   PubMed Web of Science ®Google Scholar
• Lee AYS, Körner H. The CCR6-CCL20 axis in humoral immunity and T–B cell immunobiology. Immunobiology. 2019;224(3):449–454.
   PubMed Web of Science ®Google Scholar
• Rodgers LC, Cole J, Rattigan KM, et al. The rheumatoid synovial environment alters fatty acid metabolism in human monocytes and enhances CCL20 secretion. Rheumatology (Oxford). 2020;59(4):869–878.
   PubMed Web of Science ®Google Scholar
• Su SB, Tao L, Deng ZP, et al. TLR10: insights, controversies and potential utility as a therapeutic target. Scand J Immunol. 2021;93(4):e12988.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cao R, Ying H, et al. Increased expression of TLR10 in B cell subsets correlates with disease activity in rheumatoid arthritis. Mediat Inflamm. 2018;2018:9372410–9372436.
   Web of Science ®Google Scholar
• Li ZT, Zhang X, Wang DW, et al. Overexpressed lncRNA GATA6-AS1 inhibits LNM and EMT via FZD4 through the wnt/β-Catenin signaling pathway in GC. Mol Ther Nucleic Acids. 2020;19:827–840.
   PubMedGoogle Scholar
• Zhou JG, Hua Y, Liu SW, et al. MicroRNA-1286 inhibits osteogenic differentiation of mesenchymal stem cells to promote the progression of osteoporosis via regulating FZD4 expression. Eur Rev Med Pharmacol Sci. 2020;24(1):1–10.
   PubMed Web of Science ®Google Scholar
• Mao D, Wu M, Wei J, et al. MicroRNA-101a-3p could be involved in the pathogenesis of temporomandibular joint osteoarthritis by mediating UBE2D1 and FZD4. J Oral Pathol Med. 2021;50(2):236–243.
   PubMed Web of Science ®Google Scholar
• Ma C, Xu B, Husaiyin S, et al. MicroRNA-505 predicts prognosis and acts as tumor inhibitor in cervical carcinoma with inverse association with FZD4. Biomed Pharmacother. 2017;92:586–594.
   PubMed Web of Science ®Google Scholar
• Liu T, Wang Z, Dong M, et al. MicroRNA-26a inhibits cell proliferation and invasion by targeting FAM98A in breast cancer. Oncol Lett. 2021;21(5):367.
   PubMed Web of Science ®Google Scholar
• Li Z, Li N, Sun X, et al. FAM98A promotes cancer progression in endometrial carcinoma. Mol Cell Biochem. 2019;459(1–2):131–139.
   PubMed Web of Science ®Google Scholar